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When  blood is shed,  a  soluble plasma  protein,  fibrinogen,  is  con- 
verted into  a  gel-like  mass of fbrils in the interstices  of which the 
cellular elements of the blood are retained mechanically to form the 
blood clot.  This may subsequently express serum,  the phenomenon 
of syneresis.  Table I  represents  a  condensed and greatly simplified 
summary of some of the theories which have been suggested concern- 
ing the mechanism of this transformation.  Without considering them 
individually or in detail, it is to be noted that  according to most of 
these theories, the conversion of fibrinogen to fibrin is associated with 
the liberation of an active coagulant, termed thrombin in the absence 
of any precise information as to its chemical nature.  Circulating blood 
is believed to contain various precursors of thrombin,  activators, and 
inhibiting agents in delicate balance; when blood is shed, this balance 
is somehow upset, initiating a complex series of consecutive reactions, 
as the very last step in which thrombin is formed; and this thrombin 
then reacts with plasma fibrinogen to form fibrin, the basis of the clot. 
There  have been two attempts to turn aside from what we may call these 
classical theories of coagulation as developed by Schmldt, Hammarsten, Morawitz, 
Bordet, Howell (1915-17, 1925), and others, with their complex interplay  of nu- 
merous cellular and plasma constituents, and to substitute instead relatively simple 
concepts.  Thus, Hekma has suggested that the transformation  of fibrinogen to 
fibrin is a reversible sol-gel  transformation; that fibrinogen is the alkaline hydrosol 
of fibrin, coagulation  presumably  resulting from an unexplained increase in the 
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acidity of shed blood;  and that fibrin can be converted back to fibrinogen  by 
dissolving  it in alkali.  His theory is particularly interesting in view of the fact 
that Anson and Mirsky  1 have recently succeeded  in  converting heat-denatured 
serum albumin back to the native protein by simple solution in acid and careful 
neutralization.  However, Hekma's views have failed of general acceptance.  As 
Barkan and Gaspar showed, an alkaline  solution  of fibrin is not a  solution of fib- 
rinogen,  for the former cannot be coagulated afresh by the addition of thrombin. 
Moreover, the coagulation of fibrinogen does not  necessarily  involve a  change 
in hydrogen ion concentration (Eagle and Baumberger). 
Stuber and his coworkers  have published  an extensive series of papers, in the 
earliest of which he claimed that thrombin caused coagulation by removing water 
from fibrinogen,  thereby converting it  to a  dehydrated insoluble  form, fibrin. 
Subsequently, however, he has apparently discarded the classical  theories and 
reactants as artifacts, and has introduced the wholly new idea that coagulation is 
caused by glycolysis, a concept which has not been verified.  As Hartmann and 
Kfihnau showed, plasma dialyzed free of glucose clots just as readily as normal 
plasma upon the addition of the necessary electrolytes, and normal plasma may 
coagulate without any demonstrable glycolysis.  Another concomitant of coagula- 
tion in the Stuber scheme is an increase in the pH of blood or a fibrinogen solution. 
Hirsch has reported a decrease in thepH of blood during coagulation; while Eagle 
and Baumberger have been unable to demonstrate any significant change during 
the coagulation of fibrinogen by thrombin. 
It would therefore seem that we must revert to the classical theories 
outlined in Table I  as the most promising line of attack on the general 
problem.  If-we disregard nosological differences, and seek the basic 
observations  concerning which  most  of the  classical  theories  are  in 
essential  agreement,  we  find  that  they  all  reduce  to  the  following 
broad formulation:  (1)  an unidentified substance present in cell-free 
citrated,  oxalated,  or  untreated  plasma  (prothrombin);  (2)  an  un- 
identified  substance  present  primarily  in  the  blood  platelets;  (3) 
calcium;  and  (4)  fibrinogen,  interact  to  form  an  active  coagulant, 
thrombin, and fibrin. 
Concerning the details of the reaction, however, we find conflicting 
views in the literature.  This and the following paper represent, first, 
a reinvestigation of some of the controversial aspects of the coagulation 
phenomenon,  and  second,  further  studies  of  the  mechanism  of the 
reaction. 
I The bibliography follows the second paper of this series, page 553. HARRY  EAGLE  533 
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Methods and Materials 
1. Fibrinogen.--Fibrinogen  was prepared from citrated  (0.5  per cent)  horse, 
rabbit, dog, or human plasma by four precipitations with 1.2 volumes of saturated 
NaC1.  It was sometimes necessary to add a  trace of oxalate or citrate  to the 
saturated salt, as otherwise traces of Ca in the salt caused a part of the fibrinogen 
to coagulate upon redissolving the precipitate.  A trace of sodium bicarbonate was 
added to the salt solution to keep the reaction weakly alkaline (pH 7.5-8).  After 
each precipitation, the fibrinogen was collected by filtration (usually overnight in 
the icebox),  redissolved in a  minimum volume of 0.85  per  cent NaC1,  usually 
1/2  -  1/4 that of the previous solution, and reprecipitated.  The final solution 
failed to clot upon the addition of CaCl2, due to the progressive removal of pro- 
thrombin  and  its  progressive deterioration  in  the  course of the  precipitations, 
Most of the fibrinogen used in the following experiments was prepared from horse 
plasma  obtained  from  the  Massachusetts  State  Antitoxin  Laboratory, whose 
courtesy and generosity it is a pleasure to acknowledge. 
2.  Prothrombin and  Thrombin.--Various methods have been devised for the 
preparation  of these two reagents.  For the former, Howell  (1914)  and Cekada 
precipitated plasma with acetone, dried with ether, and extracted the precipitate 
with  slightly  alkalinized  water.  Gratia  has  inoculated  oxalated  plasma  with 
staphylococci, the fibrinogen coagulating and leaving the prothrombin in solution. 
In preparing thrombin, both the serum and the clot (Herzfeld and Klinger) have 
been used.  In our hands these methods have proved cumbersome or unreliable; 
and the presence of antithrombin has proved an undesirable complication in using 
serum as thrombin. 
Fortunately,  a  simple  method was  found  2 which  consistently yielded highly 
active preparations of prothrombin and thrombin within  1 hour after obtaining 
the plasma.  Fresh citrated or oxalated plasma, preferably the former, was diluted 
with 10 to 15 volumes of cold water, and CO~ gas bubbled through for about 5 
minutes.  A precipitate formed consisting of plasma euglobulin, a portion of the 
fibrinogen, and a large part of the thrombin precursor, prothrombin (of. page 538). 
The mixture was centrifuged, the supernatant fluid discarded, and the precipitate 
redissolved in 0.85 per cent salt solution (same volume as the original pla.~rna used). 
The opalescent solution was brought to approximately pH 7.0, as by the addition 
of a trace of sodium carbonate, sodium bicarbonate, or very dilute (0.01 N) NaOH.  a 
By this simple procedure prothrombin was obtained free from serum albumin and 
free  from  thrombin-inhibitor  (antithrombin).  If  desired,  the  fibrinogen  was 
removed by heating carefully at 56°C. for 3 to 6 minutes, a procedure which caused 
2 We have since learned  that  a  similar  method was used  by Mellanby,  who 
diluted bird plasma with water and acidified with dilute acetic acid, and by Fuchs 
(1929 b). 
a Phosphate buffer (1/20 volume of M/15 phosphate at pH 8.0) is not as saris- 
factory, due to the formation of a precipitate upon the addition of calcium salts. ~m~Y  EAGLE  535 
no significant destruction of the prothrombin.  The coagulated protein was then 
removed by centrifuging or by filtration through a small coarse filter paper. 
To obtain thrombin, one need only add to the prothrombin solution 1/20 its 
volume of 0.1 ~  CaCh (1.1 per cent).  If the prothrombin had been prepared from 
untreated plasma, and the fibrinogen had not been removed, the solution dotted 
in 3 to 15 m~nutes, whereupon it was broken up thoroughly with a glass rod, and 
filtered through a very small coarse filter paper.  The filtrate was a highly active 
thrombin.  If the fibrinogen had been removed by heating the prothrombin solu- 
tion at 56°C. for about 4 minutes, no clot formed, and the solution was ready to 
use as thrombin in 15 minutes after the addition of the calcium salt. 
The thrombin solution remained serviceable for 1 to 6 days if kept in the ice 
box, gradually decreasing in activity. 
3.  Cepkalin.--Cephalin was obtained from pig brains by drying the tissue with 
acetone, extracting with ether for 3 days, evaporating the ether extract to dryness, 
and removing the acetone-soluble fraction.  The residue was taken up in ether 
as a I or 10 per cent solution, and 0.1 cc. thoroughly shaken in 10 cc. of salt solution 
to form a  0.01-0.1  per ceDt  suspension.  Although the lipoid is  referred  to as 
cephalin in the text, it was obviously a crude mixture, containing eephalin, lecithin, 
and probably other lipoids. 
4.  Platelet  Suspension  and  Platelet-Free Plasma.--Platelet-free  horse  plasma 
was prepared by centrifuging citrated plasma for two periods of 1 hour each  at 
3000 R.P.~.  The clear plasma was then passed through a Berkefeld filter.  If an 
adequate amount of CaCI~ is added to such plasma immediately after filtration, 
it clots very slowly.  After 1 hour, however, the plasma becomes completely non- 
eoagnlable by Ca unless platelets or cephalin are also added. 
The sediment of platelets obtained upon centrifuging the citrated plasma was 
washed twice in a  volume of salt solution corresponding to the original plasma 
volume, and resuspended in 1/50 the original volume, making a platelet suspension 
50 times as concentrated as the original plasma.  That such a suspension has not 
lost  its  coagulating  properties  by  the  manipulation  involved  in  the  repeated 
centrifuging was shown by the fact that the coagulation time of the platelet-free 
plasma was restored to its original value by the addition of 1/50 volume of the 
concentrated platelet suspension (cf. page 541). 
5.  Quantitative  Measurement.--One  of  the  chief  handicaps  to  the  study  of 
coagulation has been  the  use of qualitative  instead  of quantitative  technique. 
With this in mind,  the following quantitative procedure was developed, which, 
admittedly inexact, has nevertheless proved of great value.  Suppose it is neces- 
sary to compare the thrombin content of a  solution before and after a  certain 
physical or chemical manipulation.  Keeping all  external  factors such as tem- 
perature, volume, pH, salt concentration, etc., fixed, and using a constant quantity 
of all reagents except thrombiu, one measures the coagulation time in each of a 
series of tubes containing increasing quantities of thrombin.  Given this series as a 
base line, the coagulation time of the unknown solution is then determined under 536  BLOOD COAGULATION.  I 
exactly the same conditions, and the thrombin content obtained at once by inter- 
polation  (Table  II).  The same  general  method is  applicable  to  every factor 
entering into coagulation, and is used throughout this and the following paper. 
The coagulation time is determined by inverting the tube at intervals, gelation 
sufificient to prevent the contents from pouring being the criterion of coagulation. 
Care  must be taken not to shake  the contents, for coagulation  is thereby ac- 
celerated. 
Is Thrombin the Cause or Product of Coagulation? 
It  has  been  generally  believed  (Morawitz,  Howell  (1916,  1925), 
Border  (1920a, b))  that  coagulation  involves  two  entirely  distinct 
processes:  the first is the complicated series of reactions culminating 
TABLE II 
Example of Quantitative Procedure in Estimating the Relative A ctlvity of an Unknown 
Solution of Thrombin, Compared to a Standard 
Original solution of thrombin, c¢  ..... 
NaC1 added to a total of 0.2 cc.; 0.8 
cc. fibrinogen  then added. 
Coagulation time, rain  .............. 
Coagulation  time, using the unknown 
solution  of thrombin  under exactly 
the same conditions  .............. 
0.2  0.1 
1  1½ 
3½ 
0.05 
2½ 
0.025 
4 
10 
).012~ 
7 
17 
0.0062 
12 
0.003 
20 
The thrombin activity of the unknown  was therefore about 30 to 35 per cent 
of that of the original preparation. 
in the liberation of active thrombin;  the second is the interaction of 
thrombin  with  fibrinogen  to  form  fibrin.  However,  Wooldridge 
(quoted from Morawitz), and more recently Nolf, Stuber,  and Picker- 
ing  (1925,  1928)  have  maintained  that  thrombin,  like  fibrin,  is  a 
product of coagulation  rather  than  its  cause, and  that  the  reaction 
cannot be viewed as two consecutive processes. 
The prothrombin solution prepared as described on page 534, freed 
of fibrinogen by heating,  made possible  a  clear-cut  test  of the  two 
hypotheses.  If no  thrombin  forms unless fibrinogen is  also  added, 
then the contention of Wooldridge and Nolf gains credence.  On the 
other hand, if such a  fibrinogen-free solution liberates thrombin upon 
the addition of  calcium, and if the thrombin  forms in less than the 
coagulation time of the original solution,  this clearly indicates  that 
thrombin is not  a  product of coagulation, but its cause.  As shown HARRY EAGLE  537 
in  Protocol  1  the latter is correct.  Confirming Bordet  (1920a, b) the 
amount  of  thrombin  formed  upon  adding  CaC12  to  a  prothrombin 
solution is practically the same in the presence or absence  of fibrino- 
gen.  A  quantitative  study  of  the  velocity of thrombin  formation 
shows  that  coagulation  is  coincident  with  the  sudden  liberation  of 
large quantities of thrombin,  sufficient  to  cause  an  almost  instanta- 
neous coagulation  (<  15  seconds)  of  the  fibrinogen  present  in  the 
solution. 
Protocol 1.  Showing That the Liberation of Thrombin flora Prothrombin is Inde- 
pendent of the Presence of Fibrinogen, and Precedes or Is Coincident with the Actual 
Coagulation.--O.1 ce. of 0.1  u  CaCI2 was added to 1 co. of fibrinogen-free  horse 
prothrombin solution  (page 534).  Mter 1, 2, 4,  8,  16,  and 32 minutes, 0.1  co. 
was withdrawn and quickly added to 1 cc. of citrated (0.1 per cent) fibrinogen, and 
the coagulation time noted as a quantitative measure of thrombin activity. 
Time after addition of CaC12 to prothrombin, 
rain  ................................... 
Coagulation time of 1 cc. fibrinogen plus 0.1 
cc. of the prothrombin-CaC12  mixture ...... 
Prothrombin converted to thrombin, ~er cent.  0  0 
4 
32 
0  4 
8  16 
8  3 
75  100 
32  64 
3  3 
100  100 
The  coagulation  times  were  converted  to  percentage of tkrombin formed  by 
testing serially decreasing  quantities of the final thrombin solution,  as follows: 
Coagulation time of 1 cc. flbrinogen  ..... I  5  14  25 
A coagulation time of 5 minutes  =  50 per cent thrombin; of 8½ minutes  =  25 
per cent thrombin, etc. 
As indicated, between 4 and 8 minutes after adding CaCl~ to the fibrinogen-free 
prothrombin, there was a sudden liberation of thrombin.  If Ca salt was added to 
the same unheated prothrombin, containing fibrinogen,  coagulation occurred in 4t 
minutes, coincident with the sudden liberation of thrombin; and the concentration 
of thrombin in the fluid expressed from the clot was either the same or less than 
that formed in the absence of fibrinogen,  clear evidence that thrombin is not a by- 
product of coagulation. 
As was originally believed by Schmidt in 1876 (quoted from Morawitz), and 
contrary to the contention of Wooldridge (quoted from Morawitz), Nolf, Stuber, 
and Picketing (1928) the process of coagulation may therefore be separated into 
at least two distinct reactions: 
Plasma factor -t- platelet factor -b Ca --* thrombin 
Thrombin +  fibrinogen --~ fibrin. 538  BLOOD  COAGULATION.  I 
The RSle of the Plasma Factor, Prothrombin, in the Coagulation  Process 
The  term  prothrombin  (thrombin  precursor)  was  applied  to  the 
plasma factor by Schmidt long before the essential r61e zf Ca salts and 
blood platelets had been discovered.  However, the e~periments illus- 
trated in Figs. 1, 2, and 3 indicate that the term'is stir'applicable, for 
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FIG. 1.  Showing that the amount of thrombin formed depends upon the quan- 
tity of prothrombin used.  1, 2, 4, and 8 cc. of platelet-free prothrombin solution 
(page 534) +  1 cc. of a phatelet suspension tenfold concentrated as compared to the 
original plasma +  1 cc. 0.1 g CaC1, + 0.85 per cent NaC1 to 10 cc.  The thrombin 
formation was foUowed  quantitatively by the method of page 534. 
the  plasma  constituent  seems  to  be  the  true  thrombin-precursor, 
merely activated by Ca and platelets to form thrombin.  As is shown 
in the figures, the amount of thrombin ultimately formed from a mix- 
ture of these three reagents is independent of the amount of Ca, plate- 
lets,  or  cephalin  used,  but  varies  directly  with  the  amount  of the 
plasma factor.  The thrombin was measured by the method described 
on page 535.  Although the figures give the results with horse plasma, I~,RY  EAGLE  539 
similar results were obtained with dog, rabbit, and human prothrom- 
bin, using either a suspension of cephalin or platelets as the activator. 
The plasma factor has therefore been correctly termed prothrombin, 
although its chemical nature, like that of thrombin, remains unknown. 
We have been unable to confirm its ready adsorption by colloidal 
Mg(OH)~ or Cas(PO~)2 as claimed by Fuchs and Hartmann; in our 
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Fzo. 2. Showing  that platelets accelerate the rate of thrombin formation, but 
do  not affect the total quantity formed.  1 cc. horse prothrombin solution -l- 
varying amounts platelet suspension  (20-fold  concentrated) 4- NaC1 to 2 cc. + 0.1 
x CaCh 0.1 cc. 
hands only a small fraction (< 10 per cent) is so adsorbed, and that is 
difficult to recover.  The identity of prothrombin with complement 
mid-piece as claimed by yon Falkenhausen and by Fuchs (1929a, b) is 
highly questionable.  Mid-piece, by definition, is that component  of the 
hemolytic factor of fresh serum which is carried down completely upon 
dilution with H,O and slight acidification with e.g. CO,; while, as Bier 
has shown, prothrombin is only carried down in part by this procedure. 
Indeed, we have found that the supernatant fluid, restored to the proper 540  BLOOD COAGULATION.  I 
pH by the addition of NaOH (approximately 0.1 cc. of 1 NaOH per 
cc. serum used), and to proper tonicity by the addition of NaC1 (1/19 
its volume of 17 per cent solution) clots readily upon the addition of 
Ca in sufficient quantity to counteract the citrate or oxalate used in 
preparing  the plasma.  Such coagulation proves the presence of pro- 
thrombin;  measured  quantitatively,  about  half  of the  prothrombin 
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FiG. 3.  Showing that cephalin accelerates the rate of thrombin formation, but 
does not affect the total quantity formed.  1 cc. of horse prothrombin solution 
(platelet-free) +  varying amounts of a cephalin suspension +  NaC1 to 1.5 cc.  + 
0.5 cc. of 0.1 M  CaC12. 
remains in the supernatant  fluid  (end-piece),  a  finding incompatible 
with its identification as complement mid-piece. 
The use of Bordet's term serozyme instead of prothrombin  for the 
plasma factor is to be discouraged, for it implies that the substance is 
an  enzyme,  a  point  of view which  is  still  controversial.  The  term 
thrombogen used by Morawitz is as non-committal as the term  pro- 
thrombin,  and therefore equally  satisfactory. HAP.~  EAGLe-  541 
The Rale of the Platelet Factor (Cephalln?) in the Formation of Thrombin 
The  importance of the blood platelets  for  coagulation is  clearly 
shown by the fact that even partial removal by centrifuging citrated or 
oxalated blood at high speed tends to retard coagulation upon sub- 
sequent  recalcification; and  as  Cramer  and  Pringle  showed,  if  the 
platelets are removed completely, as by Berkefeld fltration,  coagula- 
tion may be completely prevented.  If the latter experiment is  re- 
peated quantitatively, one obtains results similar to those summarized 
in Fig. 4.  The addition of platelets to Berkefeld-filtered plasma causes 
a progressive and striking increase in the velocity of coagulation upon 
recalcification, from an initial coagulation time of >  3000 minutes to 
one of 1-3 minutes.  Clearly, the often-quoted fact that the blood of 
patients with purpura hemorrhagica may clot despite platelet counts 
as low as 20,000 does not disprove their participation in coagulation. 
In the experiment of Fig. 4, the original plasma dotted in 14 minutes 
upon recalcification; complete removal of the platelets by Berkefeld 
filtration rendered the plasma non-coagulable (cf. page 535);  and as 
little as 1/20 or even 1/50 of the original platelet concentration sufficed 
to restore its coagulability.  Platelet counts of even 10,000 per c.mm. 
represent a  quantity adequate to cause a  slow but complete trans- 
formation of prothrombin to thrombin and of fibrinogen to fibrin. 
The  use  of  the  terms  thrombokinase  and  thrombozyme  for  the 
platelet factor is to be discouraged, inasmuch as these terms imply that 
it is an enzyme or a coenzyme facilitating the production of thrombin, 
a  hypothesis for which there is some evidence, but which certainly 
cannot be regarded as proved. 
Howell  (1912) and  Rumpf have shown that  a  lipoid present  in 
most animal tissue, which both Howell, and Gratia and Levene have 
identified as cephalin, was an adequate substitute for platelets in  ~  the 
coagulation process.  Howell therefore suggested that when platelets 
disintegrate in shed blood they liberate cephalin, which then partici- 
pates in coagulation.  However, as  both  Howell  and  Rumpf  have 
shown, if platelets are extracted with lipoid solvents,  only a  small 
fraction  (in our hands,  less than  10  per cent)  of their coagulating 
activity is recovered in the lipoid solution.  Possibly, as Howell has 
suggested,  the  active  component of  platelets  is  a  cephalin-protein 
complex which is more efficient than the cephalin itself. 542  BLOOD COAGULATION.  I 
Numerous  workers  (Bayne-Jones,  Christie,  Davies,  and  Stewart, 
and Fuchs  (1929,  1930)  view the platelets not only as a  source of a 
cephalin-like substance,  but also  as  a  source of prothrombin.  This 
finding,  however,  we  have  been unable to confirm.  In our hands, 
horse,  rabbit, or dog platelets washed free of plasma do not contain 
significant  or  even  demonstrable  quantities  of  prothrombin,  while 
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FIG. 4.  The effect of ptatelet concentration upon the velocity of coagulation. 
Varying amounts of platelet  suspension,  50-fold concentrated  as compared  to 
the original plasma,  were added to platelet-free plasma prior to the addition  of 
CaC12.  The original plasma  dotted in 14 minutes, as  indicated  by the  arrow 
in the figure. 
their coagulating activity as platelets is quantitatively the same as in 
the original plasma  (Protocol  2). 
Protocol 2.  Showing That Platelets  Contain no Demonstrable Quantities  of Pro- 
thrombin.--A suspension of washed horse platelets in 0.85 per cent NaCI was pre- 
pared, 25-fold concentrated with respect to the original plasma  (page 535).  The 
coagulation  time of a platelet-free  horse plasma  was restored  to normal by the 
addition of 1/25 volume of this suspension (cf. Fig. 4), indicating that the eoagulat- ~P~Y  ~AOLE  543 
ing activity of the platelets had not been impaired by the washing.  To 20 cc. of 
the platdet suspension was added 1 cc. of 0.1 M CaC12 and the thrombin activity of 
the whole suspension and of the supernatant fluid tested at intervals (2, 4, 8, 16, 
32, and 64 minutes after the addition of the CaCI~).  No demonstrable thrombin 
appeared; while a  solution of prothombin prepared from the same  platelet-free 
plasma developed very active thrombin upon the addition of CaC12 and a trace of 
cephalin. 
Suspending the platelets in H20 instead of salt solution for 1 hour prior to the 
addition of CaCh and NaCI in sufficient quantity to restore isotonicity with blood 
had no effect on the results; and the use of oxalated instead of citrated blood was 
likewise  ineffective.  Qualitatively the same  results were obtained with  rabbit 
and dog platelets.  In only one instance was prothrombin demonstrated in a horse 
platelet suspension,  after treatment with H,O and CaCI,: and in that case the 
quantity was less than 1/200 :that present in the platelet-free plasma,  suggesting 
indeed  that  the  prothrombin  originated  from  traces  of  plasma  incompletely 
removed by washing, rather than the platelets themselves.  Platelets, therefore, 
have not been demonstrated to contribute significant  quantities of prothrombin; 
their effect in coagulation rests upon their eephalin-like  activity in accelerating 
the formation of thrombin. 
How  platelets  (or  cephalin)  accelerate  coagulation  has hitherto 
remained an open question.  The use of a  quantitative method dis- 
closes the fact that they do not affect the total amount of thrombin 
produced,  but  act  by accelerating the  rate  of thrombin  production 
(Protocol 3  and Figs.  2  and 3).  The more platelets used,  the more 
rapid is the appearance of thrombin and the subsequent coagulation; 
but the total amount of thrombin formed if the process is allowed to 
proceed  to  equilibrium  in  the  absence  of fibrinogen  depends  solely 
upon the amount of prothrombin used. 
Protocol 3.  Showing That  Platelets and  Cephalin Accelerate Coagulation by 
Increasing  the  Rate  of  Thrombin Formation, without Affecting the  Quantity of 
Throrabin Produced.--Prothrombin  was prepared from platelet-free horse plasma 
non-coagulable by Ca (page 534), heated to remove fibtinogen (page 534), and 1 ce. 
was placed in each of a series of tubes.  Serially increasing  quantities of a con- 
centrated platelet suspension  (page 535), or of a cephalin suspension were added, 
the volume adjusted to 2 cc., and 0.1 cc. of 0.1 M CaCh added to each tube.  At 
various intervals, 0.1 cc. of each solution was withdrawn and quickly added to 1 cc. 
of horse fibrinogen solution;  the velocity of coagulation serving as a quantitative 
measure of thrombin activity (page 535).  In plotting the results in Figs. 2 and 3, 
the maximum quantity of thrombin formed has been taken as 100. 
Similar results were obtained with rabbit and human plasma prothrombin and 
platelets. 544  BLOOD COAGULATION.  I 
Whether the platelet factor actually combines with prothrombin to 
form thrombin must remain an open question.  The fact that the total 
amount of thrombin elaborated depends solely upon the amount of 
prothrombin used (Fig. 1) and is independent of the amount of plate- 
lets  used,  strongly  suggests  that  the  platelets  merely  catalyze  the 
reaction between prothrombin and Ca, without themselves contribut- 
ing to  the compound formed.  A  decisive experiment would be the 
formation of thrombin in the complete absence of platelets or cephalin. 
If  prothrombin  is  prepared  from  platelet-free  plasma  (page  534), 
and  CaCI~  added,  thrombin does form very slowly in the  complete 
absence of platelets, (lowest curve of Fig. 3).  However, the possibility 
cannot be excluded that enough platelets  disintegrate  in  the  course 
of the centrifuging and  Berkefeld filtration to explain  the observed 
thrombin-formation.  ~ 
Whatever  the mechanism, whether a  platelet  factor actually com- 
bines with prothrombin, or whether it merely accelerates a  reaction 
which proceeds slowly even in its absence, the physiological r61e of the 
platelets in coagulation lies in the fact that they enormously accelerate 
the production of thrombin. 
No evidence was found for the view that platelets are species-specific 
in  their  coagulating  activity,  that  is,  react  specifically  with  pro- 
thrombin of the same species.  Either horse, human, rabbit,  or dog 
platelets will activate prothrombin derived from any of these species. 
SUMMARY 
1.  A  method is described for the preparation and titration of pro- 
thrombin and thrombin. 
2.  Confirming the views of Morawitz, Howell (1916-17,  1925), and 
Bordet, thrombin cannot be regarded as an artificial by-product of co- 
agulation (Wooldridge, Nolf (both quoted from Morawitz)).  Calcium, 
a  platelet  factor,  and a plasma factor (prothrombin) interact to form 
thrombin, and this then  acts  upon  fibrinogen  to  form  fibrin.  The 
4 The failure of whole platelet-free plasma  to clot despite  the formation  of 
thrombin is due to the fact that it contains antithrombin, which is more than 
sufficient to inactivate the slowly formed thrombin before the latter can coagulate 
the fibrinogen.  In the prothrombin solution there is no antlthrombin,  and even 
the slowly formed thrombin is demonstrable. HARRY EAGLE  545 
amount and rate of thrombin formation in the first reaction  are  in- 
dependent of the presence or absence of fibrinogen.  After a  variable 
latent period, thrombin suddenly appears  in large quantities,  coin- 
cident with  or  immediately preceding  the  deposition  of  fibrin  if 
fibrinogen is present. 
3.  The amount of thrombin formed in a mixture of prothrombin, 
Ca and platelets is independent of the platelet or Ca concentration, 
and depends primarily upon the amount of prothrombin used.  The 
platelets  (or cephalin)  enormously accelerate the transformation of 
prothrombin to thrombin, and this acceleration seems to be their phys- 
iological rS~e in the coagulation process. 
4.  Contrary to previous reports,  platelets have not been demon- 
strated to contain significant quantities of prothrombin. 
5.  The  available  data  do  not  allow  any  definite decision  as  to 
whether the platelet factor actually combines with prothrombin  to 
form thrombin, or merely catalyzes the transformation.  The very 
slow formation of thrombin in the complete absence of platelets may 
be due to  dissolved traces of platelet material released during the 
physical  manipulation  of  the  plasma  (centrifuging,  Berkefeld  fil- 
tration). 
6.  There was no evidence for a species-specific  activity of platelets 
in the  transformation of prothrombin  to  thrombin. 
(The bibliography for both papers is given at the end of the second 
paper (page 553).) 